In the context of cancer, the role of PRC2, and EZH2 specifically, is multifaceted as it can function both as a tumor-suppressor (14–18) and as an oncogene (17, 19–23) in a cell type dependent manner. This evidence concerns the gene EZH2 and neoplasm.